Higher cancer risk in diabetic patients can be related to the following metabolic disorders: hyperglycemia, insulin resistance, hyperinsulinemia, and elevated level of insulin-like growth factor type 1 (IGF-1). This evidence concerns the gene IGF1 and hyperinsulinism.